Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 2 |
2010 | 1 |
2013 | 2 |
2014 | 3 |
2016 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).
Am J Cardiol. 2016 Apr 15;117(8):1199-205. doi: 10.1016/j.amjcard.2016.01.014. Epub 2016 Jan 28.
Am J Cardiol. 2016.
PMID: 26940556
Free article.
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
Bangalore S, Messerli FH, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC; Treating to New Targets Steering Committee and Investigators.
Bangalore S, et al.
Eur Heart J. 2010 Dec;31(23):2897-908. doi: 10.1093/eurheartj/ehq328. Epub 2010 Sep 16.
Eur Heart J. 2010.
PMID: 20846991
Clinical Trial.
Item in Clipboard
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
Bangalore S, Fayyad R, Hovingh GK, Laskey R, Vogt L, DeMicco DA, Waters DD; Treating to New Targets Steering Committee and Investigators.
Bangalore S, et al.
Am J Cardiol. 2014 Jun 15;113(12):2018-20. doi: 10.1016/j.amjcard.2014.03.046. Epub 2014 Apr 3.
Am J Cardiol. 2014.
PMID: 24793673
Review.
Item in Clipboard
Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.
Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH; Treating to New Targets Steering Committee and Investigators.
Bangalore S, et al.
Eur Heart J. 2014 Jul 14;35(27):1801-8. doi: 10.1093/eurheartj/eht315. Epub 2013 Aug 29.
Eur Heart J. 2014.
PMID: 23990605
Clinical Trial.
Item in Clipboard
The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.
Kostis JB, Breazna A, Deedwania PC, LaRosa JC; Treating to New Targets Steering Committee and Investigators.
Kostis JB, et al.
J Clin Hypertens (Greenwich). 2008 May;10(5):367-76. doi: 10.1111/j.1751-7176.2008.07851.x.
J Clin Hypertens (Greenwich). 2008.
PMID: 18453796
Free PMC article.
Clinical Trial.
Item in Clipboard
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH; Treating to New Targets Steering Committee and Investigators.
Bangalore S, et al.
Am J Med. 2014 Jan;127(1):71-81.e1. doi: 10.1016/j.amjmed.2013.07.038. Epub 2013 Nov 7.
Am J Med. 2014.
PMID: 24210549
Clinical Trial.
Item in Clipboard
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK; Treating to New Targets Steering Committee and Investigators.
Shepherd J, et al.
Mayo Clin Proc. 2008 Aug;83(8):870-9.
Mayo Clin Proc. 2008.
PMID: 18674471
Clinical Trial.
Item in Clipboard
Cite
Cite